The report " Cancer / Tumor Profiling Market by Application ( Diagnostic , Personalized Medicine , Research ), Technique ( Genomics , Proteomics , Metabolomics , Epigenetics ), Technology ( Next-generation Sequencing , qPCR , In-situ Hybridization , Microarray ) - Forecast to 2021 ", provides a detailed overview of major drivers , restraints , challenges , opportunities , current market trends and strategies impacting the global market along with estimates and forecast of revenue .
Browse 81 market data tables and 34 figures spread through 157 pages and in-depth TOC on “ Cancer / Tumor Profiling Market by Application ( Diagnostic , Personalized Medicine , Research ), Technique ( Genomics , Proteomics , Metabolomics , Epigenetics ), Technology ( Next-generation Sequencing , qPCR , In-situ Hybridization , Microarray ) - Forecast to 2021 ”
http :// www . marketsandmarkets . com / Market-Reports / cancer-tumor-profiling-market-1250 . html Early buyers will receive 10 % customization on reports .
The global Cancer / Tumor Profiling market is poised to reach USD 61.87 Billion by 2021 from USD 25.82 Billion in 2016 , at a CAGR of 19.1 % from 2016 to 2021 .
Major factors fueling market growth are increasing number of cancer cases across the globe , the increasing utility of biomarkers , and availability of funding for cancer research . On the other hand high capital investments and low benefit ratio for biomarkers used in cancer / tumor profiling are expected to limit Cancer / Tumor Profiling market growth to a certain extent . Factors such as the increasing demand for personalized medicine and point-of-care diagnostic tests in cancer / tumor profiling are expected to offer a wide range of growth opportunities for players in the cancer / tumor profiling market .
The global Cancer / Tumor Profiling market is segmented on the basis of technology , technique , application , and region . On the basis of applications , the cancer / tumor profiling market is broadly segmented into personalized medicine , biomarker discovery , diagnostics , prognostics , and research applications . The personalized medicine segment is expected to account for the largest share of the global cancer / tumor profiling application market in 2016 . Advantages such as reduced probability to adverse drug reactions , better prediction of cancer , and better targeted therapy for the treatment of cancer are contributing to the large share of the personalized medicine segment in the cancer / tumor profiling market .
Speak to Analyst : - http :// www . marketsandmarkets . com / speaktoanalyst . asp ? id = 1250
Furthermore , based on technique , the cancer / tumor profiling market is segmented into genomics , proteomics , epigenetics , and metabolomics . The genomics segment is expected to account for the largest share of the cancer / tumor profiling technique market in 2016 . Factors such as increasing investments , grants , and funds by governments ; growing research in the field of genomics ; and rising application of genomic sequencing in diagnostics are contributing to the growth of this segment .
Based on technology , the global cancer / tumor profiling market is broadly divided into next-generation sequencing , quantitative PCR , in situ hybridization , immunohistochemistry , and microarray . The next-generation sequencing segment is expected to account for the largest share of the cancer / tumor profiling technology market in 2016 . Factors such as reduction in sequencing costs , technology advancements in sequencing platforms , research laboratories and academicians promoting the use of NGS , and increasing awareness on NGS products and services are contributing to the growth of this segment .
Enquiry Before Buying : - http :// www . marketsandmarkets . com / Enquiry _ Before _ Buying . asp ? id = 1250
North America ( comprising the U . S . and Canada ) is expected to account for the largest share of the global Cancer / Tumor Profiling market in 2016 , followed by Europe . Increasing research funding and presence of a large number of market players and research institutes are propelling the growth of the North American cancer / tumor profiling market . The Asia-Pacific region is expected to grow at the highest CAGR in the forecast period . In recent years , the Asia-Pacific market for cancer / tumor profiling has witnessed significant growth due to the rising incidence